Top Story

Noema Pharma raises $147 million to develop drugs for neurological conditions

Noema Pharma raises $147 million to develop drugs for neurological conditions

12-Dec-2024

|

By Clara Rodriguez Fernandez

Editor's Choice

General Inception acquires Enable Medicine to harness AI in drug discovery

General Inception acquires Enable Medicine to harness AI in drug discovery

12-Dec-2024

Headlines

AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3...

Eli Lilly invests $3bn in injectable drug manufacturing facility

Mitsubishi teams up with Dewpoint in $480m ALS deal

PTC Therapeutics boosted by Novartis rights deal for Huntington’s...

Novocure reports positive phase 3 results for tumor treating fields...

Portugal’s Hovione builds spray drying capacity in US and Ireland

→

In focus

Novocure reports positive phase 3 results for tumor treating fields therapy

03-Dec-2024 By Clara Rodriguez Fernandez

Achieving data integrity: Best practices for secure and reliable data management

Paid for and content provided by METTLER TOLEDO

Mitsubishi teams up with Dewpoint in $480m ALS deal

05-Dec-2024 By Jonathan Smith

Leveraging global logistics expertise for improved patient outcomes

Paid for and content provided by DHL Supply Chain

Featured

Insight

FDA grants orphan drug designation to CervoMed’s dementia drug

FDA grants orphan drug designation to CervoMed’s dementia drug

Clinical trials & development

→

AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results

AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results

10-Dec-2024

By Larissa Warneck-Silvestrin

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

21-Nov-2024

By Helen Albert

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Partner insightMore →

Powered by Ingredients + Innovation

Content provided by Univar Solutions USA

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd.

Accurate determination of resin substitution in solid phase peptide synthesis

Content provided by Almac Group

Reliability, scale, and security of supply

Content provided by Univar Solutions USA

Markets & regulatory news

→

Adragos Pharma snaps up Baccinex to expand CDMO network

Adragos Pharma snaps up Baccinex to expand CDMO network

26-Nov-2024

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024

By Liza Laws

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Drug delivery & innovation

→

Eli Lilly invests $3bn in injectable drug manufacturing facility

Eli Lilly invests $3bn in injectable drug manufacturing facility

10-Dec-2024

By Clara Rodriguez Fernandez

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

22-Nov-2024

Overcoming nonspecific binding challenges in pharmacokinetic assays

Overcoming nonspecific binding challenges in pharmacokinetic assays

14-Nov-2024

By Liza Laws

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

08-Nov-2024

By Liza Laws

Expand your knowledge

Industry Newsletters

Choose from regular, topic-based and special edition briefings

Resource centre

Discover cutting edge insight from our partners

Events & webinars

Explore our programme of live & on-demand content